Hachioji, Japan

Takeshi Hara


Average Co-Inventor Count = 3.2

ph-index = 10

Forward Citations = 447(Granted Patents)


Location History:

  • Hachioji, both of Tokyo, JP (1984)
  • Hachioji, JP (1979 - 1991)
  • Hachiooji, JP (1992)

Company Filing History:

goldMedal16 out of 1,586 
 
Teijin Limited
 patents
silverMedal1 out of 1 
 
Hidematsu Hirai
 patent
bronzeMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1979-1992

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Takeshi Hara

Introduction

Takeshi Hara is a prominent inventor based in Hachioji, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibody conjugates. With a total of 16 patents to his name, Hara's work has had a substantial impact on medical research and therapeutic applications.

Latest Patents

Among his latest patents are groundbreaking innovations such as the "Process for Preparation of Antibody Conjugates" and "Cytotoxic Antibody Conjugates and a Process for Preparation Thereof." These patents reflect his commitment to advancing the capabilities of antibody-based therapies, which are crucial in the treatment of various diseases.

Career Highlights

Throughout his career, Hara has worked with notable companies, including Teijin Limited and Hidematsu Hirai. His experience in these organizations has allowed him to refine his skills and contribute to significant projects in the biotechnology sector.

Collaborations

Hara has collaborated with esteemed colleagues such as Yasuhiko Masuho and Yoshinori Kato. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Takeshi Hara's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in medical therapies, showcasing the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…